Form D · Other Investment Fund

Revelis BioEclipse SPV LLC, a Series of Revelis SPV Master, LLC

Denver, CO · CIK 0001748549

Offering snapshot reported Sep 19, 2019 · SEC filing

Reported sold
$2.21M
Offering amount: $2.21M
Investors reported
27
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Jun 7, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.11M$2.21MJun 11, 2019: $1,883,000.00Jun 11, 2019Sep 19, 2019: $2,212,000.00Sep 19, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,883,000 → $2,212,000
  • Reported investors23 → 27

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 19, 2019Amendment$2,212,000$329,000vs Jun 11, 201927SEC filing
Jun 11, 2019Initial$1,883,000No comparison23SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06c, 3C, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-341608

Source: Form D, filed Sep 19, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Llc Assure Fund Management Ii Executive
Jeremy Neilson Executive
Llc Revelis Capital Group Director
Richard Thoms Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
2420 17th St 3rd Floor
Denver, CO, 80202